Pharmaceuticals & Biotech Italian Community
Our community narratives are driven by numbers and valuation.
Pharmaceuticals & Biotech Italian Investing Ideas
Recordati Industria Chimica e Farmaceutica
13.5% undervalued intrinsic discount
Updated
Rare Disease Expansion Will Secure International Market Opportunities
View narrativeAN
Updated 7 Sep
Recordati Industria Chimica e Farmaceutica
4.0% overvalued intrinsic discount
Rare Disease Expansion And Aging Demographics Will Sustainably Support Long-Term Earnings Power
View narrativeAN
Updated 29 Jul
Philogen
17.0% undervalued intrinsic discount
Analysts Maintain €26 Target for Philogen as Buyback and Valuations Remain Stable
View narrativeAN
Updated 26 Jun
Recordati Industria Chimica e Farmaceutica
26.8% undervalued intrinsic discount
Rare Disease Expansion And Geographic Diversification Will Drive Powerful Long Term Earnings Upside
View narrativeAN
Updated 1 Jul
Philogen
27.5% overvalued intrinsic discount
Clinical Pipeline And Radiopharmaceutical Expansion Will Pressure Margins And Future Earnings Potential
View narrativeAN
Published 9 Apr
